14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $141.16 $183.01 Tuesday, 12th Mar 2024 SGEN stock ended at $228.74. During the day the stock fluctuated 0% from a day low at $228.74 to a day high of $228.74.
90 days $141.16 $227.30
52 weeks $84.73 $227.30

Historical Seattle Genetics prices

Date Open High Low Close Volume
Mar 12, 2024 $228.74 $228.74 $228.74 $228.74 0
Mar 11, 2024 $228.74 $228.74 $228.74 $228.74 0
Mar 08, 2024 $228.74 $228.74 $228.74 $228.74 0
Mar 07, 2024 $228.74 $228.74 $228.74 $228.74 0
Mar 06, 2024 $228.74 $228.74 $228.74 $228.74 0
Mar 05, 2024 $228.74 $228.74 $228.74 $228.74 0
Mar 04, 2024 $228.74 $228.74 $228.74 $228.74 0
Mar 01, 2024 $228.74 $228.74 $228.74 $228.74 0
Feb 29, 2024 $228.74 $228.74 $228.74 $228.74 0
Feb 28, 2024 $228.74 $228.74 $228.74 $228.74 0
Feb 27, 2024 $228.74 $228.74 $228.74 $228.74 0
Feb 26, 2024 $228.74 $228.74 $228.74 $228.74 0
Feb 23, 2024 $228.74 $228.74 $228.74 $228.74 0
Feb 22, 2024 $228.74 $228.74 $228.74 $228.74 0
Feb 21, 2024 $228.74 $228.74 $228.74 $228.74 0
Feb 20, 2024 $228.74 $228.74 $228.74 $228.74 0
Feb 16, 2024 $228.74 $228.74 $228.74 $228.74 0
Feb 15, 2024 $228.74 $228.74 $228.74 $228.74 0
Feb 14, 2024 $228.74 $228.74 $228.74 $228.74 0
Feb 13, 2024 $228.74 $228.74 $228.74 $228.74 0
Feb 12, 2024 $228.74 $228.74 $228.74 $228.74 0
Feb 09, 2024 $228.74 $228.74 $228.74 $228.74 0
Feb 08, 2024 $228.74 $228.74 $228.74 $228.74 0
Feb 07, 2024 $228.74 $228.74 $228.74 $228.74 0
Feb 06, 2024 $228.74 $228.74 $228.74 $228.74 0
Click to get the best stock tips daily for free!

About Seattle Genetics

Seattle Genetics Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment of advanced or metastatic urothelial cancer; and TUKYSA, an oral small molecule tyrosine kinase inhibit... SGEN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT